Showing results (3671-3680 of 37,639) with videos related to
Sort By:
Pageof 3,764
Cancers|September 23, 2022
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing MutationRoberto Serna-Blasco, Estela Sánchez-Herrero, Lucía Robado de Lope, et al.Cancers|September 23, 2022
Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical WorkupOana A Ciobanu, Sorina C Martin, Vlad Herlea, et al.Cancers|September 23, 2022
Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and TrametinibGregoire Mondielli, Gregory Mougel, Florent Darriet, et al.Cancers|September 23, 2022
Review Article: Immune Landscape and Immunotherapy Options in Cervical CarcinomaKousain Kousar, Tahir Ahmad, Faiza Naseer, et al.Cancers|September 23, 2022
Exploring Metabolic Signatures of Ex Vivo Tumor Tissue Cultures for Prediction of Chemosensitivity in Ovarian CancerRita Mendes, Gonçalo Graça, Fernanda Silva, et al.Cancers|September 23, 2022
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 FunctionSi Won Oh, Won-Sik Shin, Seung-Taek LeeCancers|September 23, 2022
Overview of Nanoparticle-Based Approaches for the Combination of Photodynamic Therapy (PDT) and Chemotherapy at the Preclinical StageLuca Menilli, Celeste Milani, Elena Reddi, et al.Cancers|September 23, 2022
Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune MicroenvironmentSanaa Nakad Borrego, Ernst Lengyel, Katherine C KurnitCancers|September 23, 2022
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell LinesYixuan Ma, Benjamin Schulz, Nares Trakooljul, et al.Cancers|September 23, 2022
Contralesional Cortical and Network Features Associated with Preoperative Language Deficit in Glioma PatientsChunyao Zhou, Shengyu Fang, Shimeng Weng, et al.Pageof 3,764